Novo Nordisk Investigational Site

Belo Horizonte 30150-221

0 studies enrolling now · 2 studies all time

What they study most

Congenital Bleeding Disorder, Diabetes, Diabetes Mellitus, Type 2, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors

Studies at this site

• Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results — Completed
• Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia — Completed